Form 4 for GH Guardant Health, Inc.
Accepted 2025-01-16 00:00:00 ET · period of report 2025-01-15 · accession 0001576280-25-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-16 | 2025-01-15 | GH | Bell Michael Brian | CFO | F - Tax | $37.50 | -1,305 | 28.9K | -4% | -$48.9K |
| D | 2025-01-16 | 2025-01-15 | GH | Bell Michael Brian | CFO | M - OptEx | $0.00 | +3,309 | 30.2K | +12% | $0 |
| D | 2025-01-16 | 2025-01-15 | GH | Bell Michael Brian | CFO | M - OptEx | $0.00 | -3,309 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | F | D | 1,305 | $37.50 | 28,921 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 2 | Common | Common Stock | 2025-01-15 | M | A | 3,309 | $0.00 | 30,226 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-01-15 | M | D | 3,309 | $0.00 | 0 | D | $0.00 · — to — | 3,309 Common Stock | (F2) The restricted stock unit vested 25% of the shares subject to such award on January 15, 2022, and the remaining 75% of the shares subject to such award vests in substantially equal installments on each anniversary of January 15, 2022, during the three-year period thereafter. (F3) Not applicable for Restricted Stock Units. |